 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | ZS801 / Zhishan Weixin Bio
Trial initiation date: A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients (clinicaltrials.gov) - Feb 9, 2023
P1/2, N=21, Not yet recruiting, Sponsor: Institute of Hematology & Blood Diseases Hospital
Initiation date: Dec 2022 --> Mar 2023
- | ZS801 / Zhishan Weixin Bio
New P1/2 trial: A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients (clinicaltrials.gov) - Dec 7, 2022
P1/2, N=21, Not yet recruiting, Sponsor: Institute of Hematology & Blood Diseases Hospital
- | ZS801 / Zhishan Weixin Bio
New trial: The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients. (clinicaltrials.gov) - Nov 30, 2022
P=N/A, N=6, Not yet recruiting, Sponsor: Institute of Hematology & Blood Diseases Hospital